NASDAQ:PLRZ - Nasdaq - IL0011814113 - Common Stock - Currency: USD
1.54
+0.15 (+10.79%)
The current stock price of PLRZ is 1.54 USD. In the past month the price increased by 118.44%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
ABBV | ABBVIE INC | 18.53 | 336.11B | ||
AMGN | AMGEN INC | 14.77 | 164.85B | ||
GILD | GILEAD SCIENCES INC | 15.01 | 144.54B | ||
VRTX | VERTEX PHARMACEUTICALS INC | N/A | 120.61B | ||
REGN | REGENERON PHARMACEUTICALS | 12.71 | 60.80B | ||
ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 42.87B | ||
ARGX | ARGENX SE - ADR | 103.13 | 36.23B | ||
ONC | BEONE MEDICINES LTD-ADR | 7.44 | 31.54B | ||
BNTX | BIONTECH SE-ADR | N/A | 27.72B | ||
SMMT | SUMMIT THERAPEUTICS INC | N/A | 21.29B | ||
INSM | INSMED INC | N/A | 19.72B | ||
BIIB | BIOGEN INC | 8.31 | 19.27B |
Polyrizon Ltd. is a development stage biotech company, which engages in the development of nasal hydrogels. The firm is primarily engaged and specializing in the development of medical device hydrogels delivered in the form of nasal sprays, which form a thin hydrogel-based shield containment barrier in the nasal cavity that can provide a barrier against viruses and allergens from contacting the nasal epithelial tissue. Its naturally occurring building blocks, is delivered in the form of nasal sprays, and potentially functions as a biological mask with a thin shield containment barrier in the nasal cavity. The firm is focused not only on the development of intranasal products, but also on commercialization. The firm cooperates with medical specialists and researchers..
POLYRIZON LTD
HaTidhar St. 5
Ra'anana IL
Employees: 1
Phone: 97293740120
The current stock price of PLRZ is 1.54 USD. The price increased by 10.79% in the last trading session.
The exchange symbol of POLYRIZON LTD is PLRZ and it is listed on the Nasdaq exchange.
PLRZ stock is listed on the Nasdaq exchange.
POLYRIZON LTD (PLRZ) has a market capitalization of 9.18M USD. This makes PLRZ a Nano Cap stock.
POLYRIZON LTD (PLRZ) currently has 1 employees.
POLYRIZON LTD (PLRZ) has a support level at 0.69. Check the full technical report for a detailed analysis of PLRZ support and resistance levels.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
PLRZ does not pay a dividend.
POLYRIZON LTD (PLRZ) does not have a PE ratio as the earnings reported over the last twelve months were negative (-171.38).
The outstanding short interest for POLYRIZON LTD (PLRZ) is 4.78% of its float. Check the ownership tab for more information on the PLRZ short interest.
ChartMill assigns a technical rating of 1 / 10 to PLRZ.
ChartMill assigns a fundamental rating of 3 / 10 to PLRZ. No worries on liquidiy or solvency for PLRZ as it has an excellent financial health rating, but there are worries on the profitability.
Over the last trailing twelve months PLRZ reported a non-GAAP Earnings per Share(EPS) of -171.38. The EPS decreased by -329.32% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -40.18% | ||
ROE | -42.17% | ||
Debt/Equity | 0 |